Allied Healthcare Products Profit Margin

The latest profit margin for AHPIQ is -20.16% as of June 2022. That compares with 4.65% in the prior-year period — down 533.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Allied Healthcare Products's historical trend and sector peers before judging valuation or financial health.

Over the past year, AHPIQ's profit margin moved from 4.65% to -20.16% — a 533.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Allied Healthcare Products's valuation or profitability profile.

Against Healthcare companies, AHPIQ currently prints -20.16% for profit margin, while the sector average sits near 13.89%. That is roughly 245.1% below the sector mean. Large gaps often invite a closer look at Allied Healthcare Products's growth, margins, and balance sheet.

Profit Margin shows how effectively Allied Healthcare Products converts resources into returns. At -20.16%, AHPIQ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.65% in the prior-year period — down 533.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AHPIQ's profit margin (-20.16%), review year-over-year change from 4.65%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.